Ablative Solutions Inc

18 articles with Ablative Solutions Inc

• Ablative Solutions Announces Positive 12-Month Results from Study Evaluating Company's Novel Therapy for Uncontrolled Hypertension

  9/3/2019

  Data Provide Preliminary Evidence of Efficacy of the Investigational Peregrine System Kit

• Ablative Solutions Announces Enrollment and Randomization of First Patient in Global Clinical Trial Evaluating Company's Novel Therapy for Uncontrolled Hypertension

  7/23/2019

  TARGET BP Clinical Program studies renal denervation using the investigational Peregrine System Kit

• Ablative Solutions Announces Appointment of Kate Rumrill as President and Chief Executive Officer

  7/11/2019

  Veteran Leader Brings Extensive Experience from Both Pharma and Device Industries

• Ablative Solutions Announces Results from Treatment of Patients with Hypertension in the European Peregrine Post-Market Study

  3/7/2019

  Data from Post-Market Multi-Center Trial Presented in Late-Breaker at CRT 2019

• Ablative Solutions, Inc. Announces $77 Million Financing for Unique Therapeutic Approach to Treating Uncontrolled Hypertension

  1/3/2019

  Funding Will Support Global Clinical Program

• FDA Allows Ablative Solutions To Initiate Its Phase 2 TARGET-BP I Trial Of Combination Drug/Device Therapy For Hypertension Under Its IND

  9/13/2016

• Ablative Solutions Announces Presentations On Alcohol-Mediated Renal Denervation At The EuroPCR Congress 2016

  5/16/2016

• Ablative Solutions Announces First Two Patients Treated In The European Peregrine Post-Market Study For Renal Denervation

  2/16/2016

• Ablative Solutions Adds Key Opinion Leader To Its Scientific Advisory Board

  12/2/2015

• Ablative Solutions Announces CE Mark Of The Peregrine System Infusion Catheter

  5/13/2015

• Ablative Solutions Receives Innovation Award

  3/12/2015

• Ablative Solutions Welcomes Hypertension Leader TO ITS Scientific Advisory Board

  2/10/2015

• Ablative Solutions Treats The First Patient In The European CE-Mark Study For Renal Denervation

  10/14/2014

• Ablative Solutions Receives U.S. Patent For Peregrine System™ Infusion Catheter

  6/11/2014

• Ablative Solutions Strengthens Its Scientific Advisory Board

  5/6/2014

• Ablative Solutions Receives FDA Clearance For The Peregrine System™ Infusion Catheter

  4/2/2014

• Ablative Solutions ,Touting "New Renal Denervation Approach," Pulls In $9.5 Million

  2/4/2014

• Ablative Solutions Lands $8 Million for Renal Denervation Tech

  11/8/2013